Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
33.5
%Wording
Conditional
How definitive the wording is.Results for this period
Third quarter2023年10月1日〜2024年6月30日ConsolidatedJapanese GAAPNet Sales30,711¥ millionYear on year +33.5%Progress 72.0%
Operating profit8,158¥ millionYear on year +32.1%Progress 77.7%
Ordinary income8,146¥ millionYear on year +32.7%Progress 79.0%
Net income attributable to owners of the parent5,741¥ millionYear on year +24.4%Progress 79.1%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥58.56
Financial position at period-end
Total assets68,507¥ million
of which net assets 31,981 ¥ millionEquity ratio 46.7%vs. prior year-end -1.0pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥42,638 million (YoY +33.3%)
Operating profit¥10,500 million (YoY +21.7%)
Ordinary income¥10,309 million (YoY +20.7%)
Net income¥7,255 million (YoY +15.0%)
Annual Dividend Forecast¥3 → ¥4（+33.3%）
Factors Behind Changes in Business Performance
医心館事業で新たに19事業所を開設し、1事業所を増床してサービスを提供した。今後も積極的な開設と医療機関等への営業活動を進めるとしている。
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name No
Breakdown of extraordinary income (loss)Extraordinary income Item Gain on business transfer / Amount Not disclosed / Extraordinary loss Not disclosed
Depreciation and amortization¥1,299 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNo
Issued Shares at Period-End98,089,600株
Treasury Shares at Period-End1,883株
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2023年10月1日〜2024年6月30日 |
| Net Sales | ¥30,711 million (YoY +33.5%) |
| Operating profit | ¥8,158 million (YoY +32.1%) |
| Ordinary income | ¥8,146 million (YoY +32.7%) |
| Profit attributable to owners of the parent | ¥5,741 million (YoY +24.4%) |
| Net income per share | ¥58.56 |
| Equity ratio | End of the current fiscal period 46.7 / End of previous period 47.7 |
| Total assets | ¥68,507 million |
| Net assets | ¥31,981 million |
| Full-year earnings forecast | Net Sales ¥42,638 million (YoY +33.3%) / Operating profit ¥10,500 million (YoY +21.7%) / Ordinary income ¥10,309 million (YoY +20.7%) / Net income ¥7,255 million (YoY +15.0%) |
| Annual Dividend Forecast | ¥3 → ¥4（+33.3%） |
| Depreciation and amortization | ¥1,299 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Item Gain on business transfer / Amount Not disclosed / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name No |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 98,089,600株 |
| Treasury Shares at Period-End | 1,883株 |
| Factors Behind Changes in Business Performance | 医心館事業で新たに19事業所を開設し、1事業所を増床してサービスを提供した。今後も積極的な開設と医療機関等への営業活動を進めるとしている。 |
Items this document does not state (14)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.医心館事業で19事業所を新設し、1事業所を増床した。また、今後の積極的な開設と医療機関等への営業活動を進めるとしている。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.